Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment

Business Wire October 7, 2020

Exact Sciences and Pfizer Extend and Amend Cologuard® Promotion Agreement

PR Newswire October 7, 2020

ViiV Healthcare presents a new podcast about the Power of Being Seen

PR Newswire October 1, 2020

Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy

Business Wire October 1, 2020

CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China

Business Wire September 29, 2020

The World May be Nearing Treatments for the Growing Pandemic

Livemoney September 29, 2020

U.S. FDA Approves Pfizer's XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis

Business Wire September 28, 2020

Pfizer Declares Fourth-Quarter 2020 Dividend

Business Wire September 24, 2020

IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations

PR Newswire September 24, 2020

Javelin Biotech Aims to Develop Industry-Leading "Organ-on-a-Chip" Predictive Pharmacokinetics Platform in Collaboration with Pfizer Inc.

Business Wire September 23, 2020

ViiV Healthcare Announces Availability of CABENUVA and VOCABRIA in Canada

Canada NewsWire September 23, 2020

FDA Accepts Supplemental New Drug Application for Pfizer's XALKORI® (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma

Business Wire September 23, 2020

Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts

Business Wire September 22, 2020

The Top Reasons Pharmaceutical Companies are Switching to Oral Thin Films

Livemoney September 22, 2020

BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine

PR Newswire September 18, 2020

Pfizer Investor Day Features Significant Number of Pipeline Advances for COVID-19 Programs and Across Numerous Therapeutic Areas

Business Wire September 15, 2020

Dow Rockets 100+, Indexes Build on Comebacks

Livemoney September 15, 2020

Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn

PR Newswire September 15, 2020

Pfizer Hosts Virtual Investor Day

Business Wire September 14, 2020

Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial

Business Wire September 12, 2020